Braveheart Bio, Inc. is a clinical-stage biotechnology company. The Company focuses on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and related conditions by targeting overactive proteins within the heart. Braveheart Bio serves customers in the United States.
more
Refresh
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.